Question 1

What is Artivion?

Accepted Answer

Artivion is a Company.

Question 2

How often does Artivion appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 12 articles.

Question 3

When was Artivion first tracked by Ergen?

Accepted Answer

First tracked on May 18, 2026.

Question 4

When was Artivion last mentioned in news?

Accepted Answer

Last active on Jun 29, 2026.

Question 5

What is Artivion's current news sentiment?

Accepted Answer

Aggregate sentiment score: 62 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Artivion in global news coverage?

Accepted Answer

Attention score of 6, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Artivion?

Accepted Answer

Artivion acquires Endospan after FDA approval (May 18, 2026, 6 articles).

Question 8

How did the "Artivion acquires Endospan after FDA approval" event impact Artivion?

Accepted Answer

Artivion>>> acquired Endospan>>> for $135 million upfront, strengthening its position in the aortic device market and completing its aortic arch portfolio. This acquisition is expected to expand Artivion>>>'s leadership in the aortic arch market.

Question 9

How did the "Artivion AMDS Prosthesis FDA Approval" event impact Artivion?

Accepted Answer

Artivion received PMA approval for its AMDS Hybrid Prosthesis, which is expected to accelerate adoption and allow the company to fully penetrate the estimated $150 million annual U.S. market opportunity. This approval strengthens Artivion's position in aortic arch solutions.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.